Bundibugyo Ebola outbreak in DR Congo tops 1,500 cases and 500 deaths
A rare species of Ebola, the Bundibugyo virus, has killed more than 500 people in the Democratic Republic of the Congo, with over 1,500 confirmed cases as of early July. The World Health Organization declared it a public health emergency in May. The only licensed Ebola vaccine ta
The Bundibugyo virus, a distinct species within the Ebola family, is driving an outbreak in the Democratic Republic of the Congo that has confirmed over 1,500 cases and more than 500 deaths, concentrated in the northeastern province of Ituri. Neighboring Uganda has also reported cases and deaths. The World Health Organization declared the outbreak a public health emergency of international concern in May. The response is complicated by biology: the only licensed Ebola vaccine, Ervebo, was developed against the Zaire species and is not approved for Bundibugyo, and the two viruses carry different surface proteins, so immunity against one does not reliably protect against the other. Several Bundibugyo-specific vaccine candidates exist and the WHO has prioritized two for near-term evaluation, but those shots still need to clear trials. Until then, containment relies on testing, isolation, and contact tracing. Sources: WHO, CBS News, Doctors Without Borders, Gavi, CDC.